ANZSA: SARC CENTER SPOTLIGHT

The Australia and New Zealand Sarcoma Association (ANZSA) is the main organization for the Australia Sarcoma community. ANZSA aims to improve outcomes for sarcoma patients through research, education and awareness of Sarcomas and related tumors. By working with other organizations, ANZSA can fund clinical trials that help improve outcomes for Sarcoma patients in Australia and New Zealand.

Since its beginnings in 2008, ANZSA has been involved in more than 30 Sarcoma-related studies and clinical trials, both locally and internationally. The SARC032 trial is helping ANZSA and SARC to determine whether using immunotherapy and radiotherapy for the treatment of localized, high-risk soft tissue Sarcoma is more effective than giving radiotherapy alone.

“Thanks to our partnership with SARC, we were able to get the clinical trial running in Australia under the oversight of Associate Professor Angela Hong, a radiation oncologist at Chris O’Brien Lifehouse in Sydney. Currently, the trial is being run at three different sites in Australia, the Peter MacCallum Cancer Center in Melbourne, the Chris O’Brien Lifehouse in Sydney and the Princess Alexandra Hospital in Brisbane. We are excited to see what results this trial will yield and we look forward to working with SARC throughout the process.”